LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 128 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677 | -4.1% | 11,300 | +15.3% | 0.00% | 0.0% |
| Q2 2023 | $706 | -67.3% | 9,800 | -66.7% | 0.00% | 0.0% |
| Q1 2023 | $2,160 | +194.3% | 29,400 | +167.3% | 0.00% | 0.0% |
| Q4 2022 | $734 | -99.9% | 11,000 | +46.7% | 0.00% | 0.0% |
| Q3 2022 | $645,000 | -3.6% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $669,000 | -16.2% | 7,500 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $798,000 | -27.2% | 7,100 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $1,096,000 | +10.8% | 7,100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $989,000 | -14.3% | 7,100 | -19.3% | 0.00% | 0.0% |
| Q2 2021 | $1,154,000 | +152.5% | 8,800 | +193.3% | 0.00% | +100.0% |
| Q1 2021 | $457,000 | +1244.1% | 3,000 | +900.0% | 0.00% | – |
| Q2 2019 | $34,000 | -83.1% | 300 | -81.2% | 0.00% | -100.0% |
| Q1 2019 | $201,000 | -97.1% | 1,600 | -96.8% | 0.00% | -97.1% |
| Q4 2018 | $6,825,000 | +654.1% | 50,300 | +1424.2% | 0.04% | +775.0% |
| Q3 2018 | $905,000 | +68.2% | 3,300 | +26.9% | 0.00% | +100.0% |
| Q2 2018 | $538,000 | +42.0% | 2,600 | +13.0% | 0.00% | 0.0% |
| Q1 2018 | $379,000 | +63.4% | 2,300 | +35.3% | 0.00% | +100.0% |
| Q4 2017 | $232,000 | -91.8% | 1,700 | -91.9% | 0.00% | -91.7% |
| Q3 2017 | $2,845,000 | +1712.1% | 20,900 | +1507.7% | 0.01% | +1100.0% |
| Q2 2017 | $157,000 | +273.8% | 1,300 | +225.0% | 0.00% | – |
| Q1 2017 | $42,000 | +5.0% | 400 | 0.0% | 0.00% | – |
| Q4 2016 | $40,000 | -56.0% | 400 | -55.6% | 0.00% | – |
| Q3 2016 | $91,000 | -52.1% | 900 | -43.8% | 0.00% | -100.0% |
| Q2 2016 | $190,000 | +48.4% | 1,600 | +33.3% | 0.00% | 0.0% |
| Q1 2016 | $128,000 | -78.1% | 1,200 | -77.8% | 0.00% | -66.7% |
| Q4 2015 | $585,000 | -41.6% | 5,400 | -53.8% | 0.00% | -40.0% |
| Q3 2015 | $1,002,000 | – | 11,700 | – | 0.01% | – |
| Q1 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2014 | $926,000 | -47.9% | 17,400 | -54.0% | 0.00% | 0.0% |
| Q3 2014 | $1,776,000 | +71.8% | 37,800 | +127.7% | 0.00% | -20.0% |
| Q2 2014 | $1,034,000 | +2.5% | 16,600 | +10.7% | 0.01% | 0.0% |
| Q1 2014 | $1,009,000 | +2.5% | 15,000 | -19.8% | 0.01% | +25.0% |
| Q4 2013 | $984,000 | +36.1% | 18,700 | +12.0% | 0.00% | +33.3% |
| Q3 2013 | $723,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |